Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 33

Sort by

Sort Order Select

Journal Articles

Effect of Vancomycin-Resistance Enterococci Colonization Status Prior to Allogeneic Hematopoietic Cell Transplantation on Transplant Outcomes: A Single Center Retrospective Experience

Blood (2018) 132 (Supplement 1): 3386.

https://doi.org/10.1182/blood-2018-99-117646

Published: 2018

Journal Articles

Clinical Outcomes of MDS Patients Who Were Allogeneic Hematopoietic Stem Cell Transplant Candidates but Did Not Proceed with Transplantation

Blood (2018) 132 (Supplement 1): 2181.

https://doi.org/10.1182/blood-2018-99-115467

Published: 2018

Journal Articles

Cytokine Gene Polymorphisms Are Associated with Disease Response to Blinatumomab in Patients with B-Cell Acute Lymphoblastic Leukemia

Nikeshan Jeyakumar, MD, Ibrahim Aldoss, MD, Dongyun Yang, PhD, Sally Mokhtari, PhD, Ketevan Gendzekhadze, Margaret O'Donnell, MD, Joycelynne Palmer, Joo Y Song, MD, Guido Marcucci, Anthony S. Stein, MD, Stephen J Forman, Vinod A. Pullarkat, MD, Xiwei Wu, Ryotaro Nakamura, MD

Blood (2018) 132 (Supplement 1): 1549.

https://doi.org/10.1182/blood-2018-99-116859

Published: 2018

Journal Articles

MIPSS70+ V2.0 and Revised Cytogenetics Changes Predict Outcomes of Allogeneic Transplantation with Fludarabine and Melphalan Conditioning in Patients with Myelofibrosis

Blood (2018) 132 (Supplement 1): 1752.

https://doi.org/10.1182/blood-2018-99-112239

Published: 2018

Journal Articles

Long-Term Survival in Myelofibrosis after Allogeneic Hematopoietic Cell Transplantation Using Fludarabine/Melphalan Conditioning Regimen

Haris Ali, MD, Ibrahim Aldoss, MD, Dongyun Yang, PhD, Michelle Afkhami, MD, Monzr M. Al Malki, MD, Thai Cao, MD, Stephen J. Forman, MD FACP, Guido Marcucci, MD, Matthew Mei, MD, Sally Mokhtari, PhD, Ryotaro Nakamura, MD, Margaret O'Donnell, MD, Raju Pillai, MD, Vinod Pullarkat, MD MRCP, Amandeep Salhotra, MD, Anthony S. Stein, MD, David S. Snyder, MD

Blood (2017) 130 (Supplement 1): 199.

https://doi.org/10.1182/blood.V130.Suppl_1.199.199

Published: 2017

Journal Articles

Philadelphia (Ph) Chromosome ( BCR-ABL1 fusion) As a Recurrent Genetic Abnormality Among Therapy-Related Acute Leukemia

Ibrahim Aldoss, MD, Tracey Stiller, Joo Y. Song, MD, Monzr M al Malki, MD, Haris Ali, MD, Amandeep Salhotra, MD, Samer K Khaled, MD, Ahmed Aribi, MD, Popsie Gaytan, Joyce L. Murata-Collins, PhD, David S. Snyder, MD, Anthony S. Stein, MD, Margaret O'Donnell, MD, Ryotaro Nakamura, MD, Joycelynne M. Palmer, PhD, Stephen J. Forman, MD, Guido Marcucci, MD, Vinod Pullarkat, MD

Blood (2016) 128 (22): 3974.

https://doi.org/10.1182/blood.V128.22.3974.3974

Published: 2016

Journal Articles

A Phase 1 Trial of Inotuzumab in Combination with CVP (Cyclophosphamide, Vincristine, Prednisone) for Relapsed/ Refractory CD22+ Acute Leukemia (SWOG 1312)

Anjali S. Advani, MD, Anna Moseley, Michaela Liedtke, MD, Margaret O'Donnell, MD, Megan Othus, PhD, Martha P. Mims, MD PhD, Kristen O'Dwyer, MD, Harry P. Erba, MD PhD

Blood (2016) 128 (22): 1634.

https://doi.org/10.1182/blood.V128.22.1634.1634

Published: 2016

Journal Articles

Dissecting the Outcome Difference Between Children and Adolescents and Young Adults (AYAs) with Acute Lymphoblastic Leukemia (ALL)

Julie A. Wolfson, MD, Joshua Richman, MD PhD, Canlan Sun, PhD, Wendy Landier, PhD CRNP, Karen Leung, BA, Eileen P. Smith, MD, Margaret O'Donnell, MD, Smita Bhatia, MD MPH

Blood (2016) 128 (22): 1601.

https://doi.org/10.1182/blood.V128.22.1601.1601

Published: 2016

Journal Articles

A Phase I Trial of Total Marrow and Lymphoid Irradiation (TMLI)-Based Transplant Conditioning in Patients (Pts) with Relapsed/Refractory Acute Leukemia

Anthony Selwyn Stein, MD, Jeffrey Y. C. Wong, MD, Joycelynne Palmer, PhD, Margaret O'Donnell, MD, David S. Snyder, MD, Ni-Chun Tsai, Biostatition, Pablo Miguel Parker, MD, Ricardo Spielberger, MD, Len Farol, MD, Guido Marcucci, MD, Eric Radany, MD, Tim Schultheiss, MD, An Liu, MD, Ibrahim Aldoss, MD, Stephen J. Forman, MD

Blood (2015) 126 (23): 735.

https://doi.org/10.1182/blood.V126.23.735.735

Published: 2015

Journal Articles

Do Changes in Transplant Practice Influence Risk of Therapy-Related Myelodysplasia/ Acute Myeloid Leukemia after Autologous Hematopoietic Cell Transplantation (aHCT) for Non-Hodgkin Lymphoma (NHL)?

Can-Lan Sun, Jennifer Berano-Teh, Patrick Halliday, Lindsey Hageman, Maya Ramamurthy, Saro Armenian, Alicia Gonzales, Liezl Atencio, Liton Francisco, F. Lennie Wong, Auayporn Nademanee, MD, Robert W Chen, MD, Margaret O'Donnell, Joseph Rosenthal, Leslie L. Popplewell, MD, Shirong Wang, Stephen J. Forman, Ravi Bhatia, Smita Bhatia, PhD

Blood (2014) 124 (21): 430.

https://doi.org/10.1182/blood.V124.21.430.430

Published: 2014

Journal Articles

Randomized Trial of a Novel CMV Vaccine (CMVPepVax) after Allogeneic HCT: Elevated CMV-Specific Immune Response, Reduction in Chronic GvHD and CMV Reactivation Only in Vaccine Arm Patients

Ryotaro Nakamura, MD, Corinna La Rosa, PhD, Jeff Longmate, PhD, Margaret O'Donnell, MD FRCPC, Ji-Lian Cai, MD, Len Farol, MD, Amandeep Salhotra, MD, David S Snyder, MD, Jennifer Drake, Cynthia Slape, James Merson, PhD, John A Zaia, MD, Stephen J. Forman, Don J. Diamond, PhD

Blood (2014) 124 (21): 183.

https://doi.org/10.1182/blood.V124.21.183.183

Published: 2014

Journal Articles

Minimal Residual Disease Detection By Next Generation Sequencing in Adult B-Cell Acute Lymphoblastic Leukemia (ALL) Patients Treated on SWOG Trial S0333

Olga Sala Torra, MD, Megan Othus, PhD, David W Williamson, PhD, Brent L. Wood, MD PhD, Ilan Kirsch, MD, Harlan Robins, PhD, Margaret O'Donnell, Stephen J. Forman, Frederick R. Appelbaum, MD, Jerald P Radich, MD

Blood (2014) 124 (21): 2399.

https://doi.org/10.1182/blood.V124.21.2399.2399

Published: 2014

Journal Articles

Southwest Oncology Group Study S0910: A Phase 2 Trial of Clofarabine/ Cytarabine/ Epratuzumab for Relapsed/ Refractory Acute Lymphocytic Leukemia.

Anjali Advani, MD, Shannon McDonough, Steven Coutre, MD, Brent L. Wood, MD, PhD, Jerald P. Radich, MD, Martha Mims, MD, Margaret O'Donnell, M.D., F.R.C.P.C., Stephanie Elkins, MD, Michael W. Becker, MD, Megan Othus, PhD, Frederick R. Appelbaum, MD

Blood (2012) 120 (21): 2603.

https://doi.org/10.1182/blood.V120.21.2603.2603

Published: 2012

Journal Articles

Phase I Trial of Escalated Doses of Targeted Marrow Radiation Delivered by Tomotherapy Combined with Etoposide and Cyclophosphamide; An Allogeneic HCT Preparative Regimen for Patients with Advanced Leukemia

Anthony Selwyn Stein, MD, Jeffrey Wong, MD, Joycelynne Palmer, PhD, Margaret O'Donnell, MD, David S. Snyder, MD, Ni-Chun Tsai, MS MPH, Pablo Parker, MD, Len Farol, MD, Ricardo Spielberger, MD, Firoozeh Sahebi, MD, Neil Kogut, MD, Joyce Murata-Collins, PhD, David Senitzer, PhD, Stephen J. Forman, MD

Blood (2012) 120 (21): 218.

https://doi.org/10.1182/blood.V120.21.218.218

Published: 2012

Journal Articles

Extramedullary Relapse Following Reduced Intensity AlloHCT for Adult AML.

Neil Martin Kogut, MD, Joycelynne Palmer, PhD, Ni-Chun Tsai, MS, Joyce Collins, PhD, Margaret O'Donnell, M.D., F.R.C.P.C., Anthony Selwyn Stein, M.D., Ricardo Spielberger, MD, Stephen Forman, MD

Blood (2010) 116 (21): 3467.

https://doi.org/10.1182/blood.V116.21.3467.3467

Published: 2010

Journal Articles

Analysis of CRLF2/JAK Expression and Mutation Status In Adult ALL Patients

Olga Sala Torra, Holly Gundacker, Galina Pogosov, Era Pogosova-Agadjanyan, Stephen J Forman, Margaret O'Donnell, M.D., F.R.C.P.C., Frederick R. Appelbaum, MD, Cheryl L. Willman, MD, Jerald P. Radich, MD

Blood (2010) 116 (21): 758.

https://doi.org/10.1182/blood.V116.21.758.758

Published: 2010

Journal Articles

Early Mortality After Hematopoietic Cell Transplantation (HCT) for Hematologic Malignancies Performed In the Recent Era

Lester A. Laddaran, B.A., Can-Lan Sun, Ph.D., Ari M. VanderWalde, MD, MPH, Liton Francisco, B.S., Saro Armenian, D.O., M.P.H., Jennifer Berano Teh, M.D., F. Lennie Wong, Ph.D., Chatchada Karanes, MD, Neil Martin Kogut, MD, Amrita Krishnan, M.D., Auayporn Nademanee, M.D., Margaret O'Donnell, M.D., F.R.C.P.C., Pablo Parker, M.D., Leslie Popplewell, M.D., Anthony Selwyn Stein, M.D., Stephen J. Forman, M.D., Smita Bhatia

Blood (2010) 116 (21): 902.

https://doi.org/10.1182/blood.V116.21.902.902

Published: 2010

Journal Articles

A phase II pilot study of tacrolimus/sirolimus GVHD prophylaxis for sibling donor hematopoietic stem cell transplantation using 3 conditioning regimens

Roberto Rodriguez, Ryotaro Nakamura, Joycelynne M. Palmer, Pablo Parker, Sepideh Shayani, Auyaporn Nademanee, David Snyder, Vinod Pullarkat, Neil Kogut, Joseph Rosenthal, Eileen Smith, Chatchada Karanes, Margaret O'Donnell, Amrita Y. Krishnan, David Senitzer, Stephen J. Forman

Blood (2010) 115 (5): 1098–1105.

https://doi.org/10.1182/blood-2009-03-207563

Published: 2010

Journal Articles

Amonafide L-Malate (AS1413) in Combination with Cytarabine Is Equally Effective in Older and Younger Patients with Secondary Acute Myeloid Leukemia (AML); Final Data From a Phase II Study.

Harry P Erba, Margaret O'Donnell, Steven L Allen, Maria R Baer, Bayard L Powell, Richard M Stone, John M Bennett, Ante S Lundberg, Robert L Capizzi, David A Rizzieri

Blood (2009) 114 (22): 1047.

https://doi.org/10.1182/blood.V114.22.1047.1047

Published: 2009

Journal Articles

A Retrospective Analysis of Using Pre-Transplant Functional FDG-PET to Predict for Relapse and Survival in Relapsed Hodgkin Lymphoma (HL) Patients Undergoing Autologous Hematopoietic Cell Transplantation (AHCT).

Robert Chen, MD, Joycelynne Palmer, PHD, Leslie Popplewell, MD, Ni-Chun Tsai, MS, Amrita Krishnan, MD, FACP, Margaret O'Donnell, MD, Ryotaro Nakamura, MD, Eileen Smith, MD, Stephen J Forman, MD, Auayporn P. Nademanee, MD

Blood (2009) 114 (22): 1225.

https://doi.org/10.1182/blood.V114.22.1225.1225

Published: 2009

NARROW

Effect of Vancomycin-Resistance Enterococci Colonization Status Prior to Allogeneic Hematopoietic Cell Transplantation on Transplant Outcomes: A Single Center Retrospective Experience

Clinical Outcomes of MDS Patients Who Were Allogeneic Hematopoietic Stem Cell Transplant Candidates but Did Not Proceed with Transplantation

Cytokine Gene Polymorphisms Are Associated with Disease Response to Blinatumomab in Patients with B-Cell Acute Lymphoblastic Leukemia

MIPSS70+ V2.0 and Revised Cytogenetics Changes Predict Outcomes of Allogeneic Transplantation with Fludarabine and Melphalan Conditioning in Patients with Myelofibrosis

Long-Term Survival in Myelofibrosis after Allogeneic Hematopoietic Cell Transplantation Using Fludarabine/Melphalan Conditioning Regimen

Philadelphia (Ph) Chromosome ( BCR-ABL1 fusion) As a Recurrent Genetic Abnormality Among Therapy-Related Acute Leukemia

A Phase 1 Trial of Inotuzumab in Combination with CVP (Cyclophosphamide, Vincristine, Prednisone) for Relapsed/ Refractory CD22+ Acute Leukemia (SWOG 1312)

Dissecting the Outcome Difference Between Children and Adolescents and Young Adults (AYAs) with Acute Lymphoblastic Leukemia (ALL)

A Phase I Trial of Total Marrow and Lymphoid Irradiation (TMLI)-Based Transplant Conditioning in Patients (Pts) with Relapsed/Refractory Acute Leukemia

Do Changes in Transplant Practice Influence Risk of Therapy-Related Myelodysplasia/ Acute Myeloid Leukemia after Autologous Hematopoietic Cell Transplantation (aHCT) for Non-Hodgkin Lymphoma (NHL)?

Randomized Trial of a Novel CMV Vaccine (CMVPepVax) after Allogeneic HCT: Elevated CMV-Specific Immune Response, Reduction in Chronic GvHD and CMV Reactivation Only in Vaccine Arm Patients

Minimal Residual Disease Detection By Next Generation Sequencing in Adult B-Cell Acute Lymphoblastic Leukemia (ALL) Patients Treated on SWOG Trial S0333

Southwest Oncology Group Study S0910: A Phase 2 Trial of Clofarabine/ Cytarabine/ Epratuzumab for Relapsed/ Refractory Acute Lymphocytic Leukemia.

Phase I Trial of Escalated Doses of Targeted Marrow Radiation Delivered by Tomotherapy Combined with Etoposide and Cyclophosphamide; An Allogeneic HCT Preparative Regimen for Patients with Advanced Leukemia

Extramedullary Relapse Following Reduced Intensity AlloHCT for Adult AML.

Analysis of CRLF2/JAK Expression and Mutation Status In Adult ALL Patients

Early Mortality After Hematopoietic Cell Transplantation (HCT) for Hematologic Malignancies Performed In the Recent Era

A phase II pilot study of tacrolimus/sirolimus GVHD prophylaxis for sibling donor hematopoietic stem cell transplantation using 3 conditioning regimens

Amonafide L-Malate (AS1413) in Combination with Cytarabine Is Equally Effective in Older and Younger Patients with Secondary Acute Myeloid Leukemia (AML); Final Data From a Phase II Study.

A Retrospective Analysis of Using Pre-Transplant Functional FDG-PET to Predict for Relapse and Survival in Relapsed Hodgkin Lymphoma (HL) Patients Undergoing Autologous Hematopoietic Cell Transplantation (AHCT).

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only